Location History:
- Tokyo, JP (2012)
- Chuo-ku, JP (2014)
Company Filing History:
Years Active: 2012-2014
Title: **Innovations by Inventor Takeshi Terasawa in the Pharmaceutical Field**
Introduction
Takeshi Terasawa is an accomplished inventor based in Chuo-ku, Japan, recognized for his contributions to innovations in the pharmaceutical sector. With a total of two patents to his name, Terasawa has dedicated his research to developing novel compounds that address critical health challenges.
Latest Patents
Takeshi's latest patents include the development of a **fused ring pyridine compound**. This innovative compound has shown promise in preventing and treating cannabinoid receptor type 2-related diseases through its agonist action on the cannabinoid receptor type 2. The extensive research conducted by Terasawa and his team confirmed the compound's efficacy as a valuable agent against inflammatory diseases and pain.
His other significant patent is focused on **amide derivatives as ROCK inhibitors**. This invention encompasses novel amide derivatives and their salts, specifically designed to inhibit Rho-associated protein kinase (ROCK). It also details a pharmaceutical composition and therapeutic methods for utilizing these compounds in the treatment and prevention of ROCK-related diseases.
Career Highlights
Takeshi Terasawa is currently associated with Astellas Pharma GmbH, where he contributes his expertise in drug development and pharmaceutical innovation. His focus on discovering compounds that can effectively address various diseases has positioned him as a notable figure within the company.
Collaborations
Throughout his career, Terasawa has collaborated with esteemed colleagues such as Kouzo Sawada and Tatsuya Zenkoh. These partnerships have facilitated the advancement of his research, enabling the exploration of novel therapeutic avenues.
Conclusion
In summary, Takeshi Terasawa is a distinguished inventor whose work in developing cutting-edge pharmaceutical compounds has the potential to revolutionize treatments for various health conditions. His patents embody a commitment to addressing pressing medical needs and contribute significantly to the innovation landscape in pharmacology.